rhodamine 123 has been researched along with paraoxon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Cruz, OJ; Tai, HL; Uckun, FM | 1 |
| Chambers, JE; Gallagher, E; Minn, I; Searson, PC | 1 |
2 other study(ies) available for rhodamine 123 and paraoxon
| Article | Year |
|---|---|
Antileukemic activity and cellular metabolism of the aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07).
Topics: Animals; Antimetabolites, Antineoplastic; Biotransformation; Carboxylic Ester Hydrolases; Cell Division; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Dideoxynucleotides; Drug Resistance, Multiple; Embryo, Nonmammalian; Glutathione; Humans; Leukemia; Nucleosides; Paraoxon; Rhodamine 123; Subcellular Fractions; Tetrazolium Salts; Thiazoles; Thymidine Monophosphate; Tumor Stem Cell Assay; Zebrafish; Zidovudine | 2005 |
In vitro characterization of pralidoxime transport and acetylcholinesterase reactivation across MDCK cells and stem cell-derived human brain microvascular endothelial cells (BC1-hBMECs).
Topics: Acetylcholinesterase; Animals; Biological Transport; Brain; Capillary Permeability; Cell Line; Cholinesterase Inhibitors; Cholinesterase Reactivators; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Endothelial Cells; Fluorescent Dyes; Humans; Microvessels; Paraoxon; Parathion; Pralidoxime Compounds; Rhodamine 123 | 2016 |